ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney"

  • 2017 American Transplant Congress

    Deciphering the Mechanism of Remote Ischemic Preconditioning and Its Potential Benefits in Ischemia/Reperfusion Injury by Metabolomics.

    S. Cho, S.-I. Min, S.-Y. Kim, M.-J. Cho, W. Cho, S. Ahn, S.-K. Min, J. Ha.

    Surgery, Seoul National University Hospital, Seoul, Korea

    IntroductionRemote ischemic preconditioning (RIPC) is a strategy inducing resistance against ischemia and reperfusion(IR) injury. But the mechanism and the time window of protection representing RIPC…
  • 2017 American Transplant Congress

    Prescription Opioid Use Before and After Kidney Transplant: Implications for Post-Transplant Outcomes.

    K. Lentine,1 N. Lam,2 D. Segev,3 D. Axelrod,4 Z. Zhang,1 H. Xiao,1 G. Hess,5 B. Kasiske,6 R. Gadi,1 R. Devraj,7 D. Brennan,8 H. Randall,1 M. Schnitzler.1,6

    1St. Louis Univ, St. Louis, MO; 2Univ Alberta, Edmonton, AB, Canada; 3Johns Hopkins, Baltimore, MD; 4East Carolina Univ, Greenville, NC; 5Symphony Health, Philadelphia, PA; 6Scientific Registry of Transplant Recipients, Minneapolis, MN; 7Southern Illinois Univ, Edwardsville, IL; 8Washington Univ, St. Louis, MO

    We previously identified associations of opioid use before kidney transplant (KTx) with post-KTx complications.To confirm and extend these findings, we examined a novel database wherein…
  • 2017 American Transplant Congress

    Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.

    T. Schachtner,1,2 P. Reinke.1,2

    1Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; 2Berlin-Brandenburg Center for Regenerative Therapies, Charite Campus Virchow Clinic, Berlin, Germany

    The rising prevalence of end-stage renal disease and chronic organ shortage calls more people upon to consider living kidney donation. The benefits for recipients and…
  • 2017 American Transplant Congress

    Twelve Hour Ex Vivo Normothermic Perfusion for the Assessment of High-Risk Discarded Deceased Donor Kidneys.

    I. Palma, I. Palma, Y. Smolin, S. Kabagambe, A. Perry, J. Sageshima, R. Perez.

    Department of Surgery, UC Davis Medical Center, Sacramento, CA

    Ex-Vivo Normothermic Perfusion (EVNP) has been shown to be useful to assess viability of high-risk deceased donor kidneys, with high renal blood flow and immediate…
  • 2017 American Transplant Congress

    Immunosuppressant Costs for Medicare Part D and Kidney Transplant Recipients Since the Introduction of Generic Formulations in an Incident Kidney Transplant Population.

    M. Helmuth,1 M. Turenne,1 J. Park,2 Q. Liu,1 M. Oguntimein,3 S. Dutcher,3 R. Balkrishnan,4 J. Zee,1 A. Smith,1 A. Leichtman.1

    1Arbor Research Collaborative for Health, Ann Arbor, MI; 2U of Michigan, Ann Arbor, MI; 3Food and Drug Administration, Silver Spring, MD; 4U of Virginia, Charlottesville, VA

    Background: Substitution of generics (GEN) for brand name (BN) immunosuppressants (IS) has increased in kidney transplant recipients (KTR) since the introduction of GEN mycophenolate mofetil…
  • 2017 American Transplant Congress

    The Associations Between Immunosuppression Use, Loss of Medicare and Kidney Allograft Outcomes.

    A. Hart,1,2 S. Gustafson,2 A. Wey,2 N. Hadley,2 A. Israni.2

    1Hennepin County Medical Center, Minneapolis; 2Scientific Registry of Transplant Recipients, Minneapolis

    Medicare coverage for kidney transplant recipients aged <65 years in the US ends 3 years posttransplant, but a significant proportion of recipients remain on Medicare…
  • 2017 American Transplant Congress

    Factors Predicting 30-Day Hospital Readmission After Kidney Transplant.

    J. Ostrem, M. Brokhof, N. Kenyon, E. Hollinger, S. Jensik, O. Olaitan, M. Hertl, N. Alvey.

    Rush University Medical Center, Chicago, IL

    Background: Hospital readmissions after kidney transplant have been associated with increased morbidity, mortality, decreased quality of life, and increased healthcare costs. The objective of this…
  • 2017 American Transplant Congress

    Evolution of Health Related Quality of Life (HRQOL) in Kidney Donors.

    H. Ibrahim,1 D. Berglund,1 S. Jackson,2 A. Matas.1

    1U of MN, Mpls; 2M Health, Mpls

    Most living donors (LDs) enjoy excellent HRQOL after donation. However, most studies addressing HRQOL in this group have ascertained HRQOL related outcomes only at one…
  • 2017 American Transplant Congress

    The Use of a Furosemide Stress Test (FST) for Assessment of Discarded Deceased Donor Kidneys in an Ex-Vivo Normothermic Perfusion Model.

    I. Palma, Y. Smolin, S. Kabagambe, A. Perry, I. Palma, J. Sageshima, R. Perez.

    Department of Surgery, UC Davis Medical Center, Sacramento, CA

    Studies have shown that Ex-Vivo Normothermic Perfusion (EVNP) has the potential to assess viability and function of high-risk deceased donor kidneys. A diuretic response to…
  • 2017 American Transplant Congress

    Costimulatory Blockade in Delayed Graft Function.

    J. Von Visger,1 A. Diez,1 U. Nori,1 T. Pesavento,1 R. Pelletier,2 A. Rajab,2 A. El Hinnawi,2 H. Winters.3

    1Medicine, The Ohio State University, Columbus, OH; 2Surgery, The Ohio State University, Columbus, OH; 3Pharmacy, The Ohio State University, Columbus, OH

    Background: Delayed graft function (DGF) contributes to higher risk of rejection, poorer graft survival, hospital length of stay (LOS), and other morbidities. Studies also suggest…
  • « Previous Page
  • 1
  • …
  • 81
  • 82
  • 83
  • 84
  • 85
  • …
  • 101
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences